Clinical Trials Logo

Axial Spondyloarthritis clinical trials

View clinical trials related to Axial Spondyloarthritis.

Filter by:

NCT ID: NCT02011386 Completed - Clinical trials for Axial Spondyloarthritis

Novel MRI ANd Biomarkers in GOlimumab-treated Patients With Axial Spondyloarthritis

MANGO
Start date: February 2013
Phase:
Study type: Observational

The study investigates different criteria for remission based on MRI and circulating biomarkers for inflammation, cartilage, connective tissue and bone turnover in patients with axial spondyloarthritis treated with Golimumab. Furthermore, the study also investigates factors that affect disease activity, function and participation by use of different questionnaires.

NCT ID: NCT01808118 Completed - Clinical trials for Axial Spondyloarthritis

Continuing Versus Withdrawing Adalimumab in Maintaining Remission in Non-Radiographic Axial Spondyloarthritis

Start date: April 16, 2013
Phase: Phase 3
Study type: Interventional

The objective of this multicenter, randomized, double-blind study was to evaluate the efficacy and safety of continuing versus withdrawing therapy with adalimumab 40 mg given every other week SC in maintaining remission in subjects with moderate to severe non-radiographic axial spondyloarthritis.

NCT ID: NCT01298531 Completed - Clinical trials for Axial Spondyloarthritis

A Study to Evaluate the NSAIDS Sparing Effect of Etanercept in Subjects With Axial Spondyloarthritis

SPARSE
Start date: May 2011
Phase: Phase 4
Study type: Interventional

This study will compare the Non Steroidal Anti-Inflammatory Drugs (NSAIDs) sparing effect of etanercept with that of placebo in adult subjects with axial Spondyloarthritis.

NCT ID: NCT00939003 Completed - Clinical trials for Axial Spondyloarthritis

Study of Adalimumab in Patients With Axial Spondyloarthritis

Start date: July 2009
Phase: Phase 3
Study type: Interventional

This study will evaluate how well adalimumab works in the short and long term in patients with axial spondyloarthritis who are not diagnosed as having either ankylosing spondylitis or psoriatic arthritis.

NCT ID: NCT00844805 Completed - Clinical trials for Ankylosing Spondylitis

Infliximab for Treatment of Axial Spondyloarthritis (P05336 AM1)

INFAST
Start date: September 2009
Phase: Phase 3
Study type: Interventional

The primary objective of this study was to assess the proportion of participants in the infliximab plus naproxen arm versus the placebo plus naproxen arm, in a population of participants with moderate-to-severe active axial spondyloarthritis and disease duration of ≤3 years, who achieve the Assessment in Ankylosing Spondylitis (ASAS) partial remission criteria.

NCT ID: NCT00726765 Completed - Clinical trials for Axial Spondyloarthritis

Diagnostic Criteria in the Diagnosis of Spinal Spondyloarthropathies in Patients With Chronic Low Back Pain (Study P05320)(COMPLETED)

Start date: June 2008
Phase: N/A
Study type: Observational

This is a multi-national, multi-site, observational study to determine which of two strategies, when used by referring physicians is superior in the diagnosis of axial spondyloarthritis (AS) by rheumatologists.